Staar Surgical Co logo

Staar Surgical Co

FRA:SR3 (USA)   Ordinary Shares
€ 36.73 (-2.78%) Jun 5
131.00
P/B:
5.05
Market Cap:
€ 1.83B ($ 1.99B)
Enterprise V:
€ 1.64B ($ 1.78B)
Volume:
-
Avg Vol (2M):
180.00
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Staar Surgical Co ( ) from 1990 to Jun 06 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Staar Surgical stock (FRA:SR3) PE ratio as of Jun 06 2024 is 131. More Details

Staar Surgical Co (FRA:SR3) PE Ratio (TTM) Chart

To

Staar Surgical Co (FRA:SR3) PE Ratio (TTM) Historical Data

Total 1252
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Staar Surgical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-06 127.5 2024-04-03 127.1
2024-06-05 127.5 2024-04-02 125.7
2024-06-04 131.2 2024-03-28 120.1
2024-06-03 132.6 2024-03-27 83.0
2024-05-31 129.3 2024-03-26 85.5
2024-05-30 127.4 2024-03-25 84.6
2024-05-29 129.9 2024-03-22 89.5
2024-05-28 130.7 2024-03-21 90.3
2024-05-27 130.9 2024-03-20 88.2
2024-05-24 134.8 2024-03-19 87.7
2024-05-23 135.9 2024-03-18 86.3
2024-05-22 135.2 2024-03-15 88.4
2024-05-21 136.0 2024-03-14 86.8
2024-05-20 135.7 2024-03-13 85.6
2024-05-17 135.5 2024-03-12 88.5
2024-05-16 137.0 2024-03-11 86.8
2024-05-15 139.3 2024-03-08 80.0
2024-05-14 139.6 2024-03-07 81.1
2024-05-13 135.9 2024-03-06 76.4
2024-05-10 137.6 2024-03-05 79.2
2024-05-09 131.6 2024-03-04 76.4
2024-05-08 150.1 2024-03-01 72.2
2024-05-07 147.6 2024-02-29 72.6
2024-05-06 148.0 2024-02-28 75.2
2024-05-03 146.8 2024-02-27 70.0
2024-05-02 144.0 2024-02-26 70.6
2024-04-30 152.9 2024-02-23 70.3
2024-04-29 151.7 2024-02-22 70.2
2024-04-26 152.6 2024-02-21 70.9
2024-04-25 153.0 2024-02-20 71.3
2024-04-24 155.8 2024-02-19 71.4
2024-04-23 151.0 2024-02-16 72.4
2024-04-22 150.8 2024-02-15 69.5
2024-04-19 150.9 2024-02-14 68.7
2024-04-18 150.3 2024-02-13 72.5
2024-04-17 151.7 2024-02-12 69.7
2024-04-16 150.2 2024-02-09 70.2
2024-04-15 162.0 2024-02-08 68.6
2024-04-12 166.6 2024-02-07 71.9
2024-04-11 164.5 2024-02-06 64.2
2024-04-10 166.6 2024-02-05 64.3
2024-04-09 165.7 2024-02-02 65.9
2024-04-08 155.1 2024-02-01 64.7
2024-04-05 145.5 2024-01-31 66.9
2024-04-04 145.7 2024-01-30 70.7

Staar Surgical Co (FRA:SR3) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Staar Surgical Co logo
Staar Surgical Co
NAICS : 339115 SIC : 3851
ISIN : US8523123052

Share Class Description:

FRA:SR3: Ordinary Shares
Description
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.